Characteristics of subtype III-A CRISPR-Cas system in Mycobacterium tuberculosis: An overview

被引：4

作者：

Hamdi, Insaf ^{[1
]}

Boni, Funmilayo ^{[1
]}

Shen, Qinglei ^{[1
]}

Moukendza, Liadrine ^{[1
]}

Peibo, Li ^{[2
]}

Jianping, Xie ^{[1
,2
]}

机构：

[1] Southwest Univ, Inst Modern Biopharmaceut,Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Ecoenvironm Three Gorges Reservoir Reg,Min, Chongqing 400715, Peoples R China

[2] Southwest Univ, Publ Hlth Hosp, Chongqing Publ Hlth Med Ctr, Chongqing 400030, Peoples R China

来源：

INFECTION GENETICS AND EVOLUTION | 2023年 / 112卷

关键词：

Mycobacterium tuberculosis; CRISPR-Cas III-A; Reverse transcriptase (RT); Housekeeping nuclease-anti-CRISPR; CRISPRi; COMPLEX; RNA; BACTERIA; CLASSIFICATION; MECHANISMS; KNOCKDOWN; INSIGHTS; ROLES;

D O I：

10.1016/j.meegid.2023.105445

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

CRISPR-Cas systems are the only RNA- guided adaptive immunity pathways that trigger the detection and destruction of invasive phages and plasmids in bacteria and archaea. Due to its prevalence and mystery, the Class 1 CRISPR-Cas system has lately been the subject of several studies. This review highlights the specificity of CRISPR-Cas system III-A in Mycobacterium tuberculosis, the tuberculosis-causing pathogen, for over twenty years. We discuss the difference between the several subtypes of Type III and their defence mechanisms. The antiCRISPRs (Acrs) recently described, the critical role of Reverse transcriptase (RT) and housekeeping nuclease for type III CRISPR-Cas systems, and the use of this cutting-edge technology, its impact on the search for novel anti-tuberculosis drugs.

引用

页数：11

共 50 条

[21] Structural and biochemical analysis of a Type III-A CRISPR-Cas system supports the idea of a Cas10-activating region
Khweis, Sarah
Blackburn, Mason
Dunkle, Jack
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S636 - S636
[22] The effect of crRNA-target mismatches on cOA-mediated interference by a type III-A CRISPR-Cas system
Nasef, Mohamed
Khweis, Sarah A.
Dunkle, Jack A.
RNA BIOLOGY, 2022, 19 (01) : 1293 - 1304
[23] Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus
Cao, Linyan
Gao, Chun-Hui
Zhu, Jiade
Zhao, Liping
Wu, Qingfa
Li, Min
Sun, Baolin
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 306 (08) : 686 - 696
[24] Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts
Gregory W. Goldberg
Elizabeth A. McMillan
Andrew Varble
Joshua W. Modell
Poulami Samai
Wenyan Jiang
Luciano A. Marraffini
Nature Communications, 9
[25] Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts
Goldberg, Gregory W.
McMillan, Elizabeth A.
Varble, Andrew
Modell, Joshua W.
Samai, Poulami
Jiang, Wenyan
Marraffini, Luciano A.
NATURE COMMUNICATIONS, 2018, 9
[26] The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems
Paraan, Mohammadreza
Nasef, Mohamed
Chou-Zheng, Lucy
Khweis, Sarah A. A.
Schoeffler, Allyn J. J.
Hatoum-Aslan, Asma
Stagg, Scott M. M.
Dunkle, Jack A. A.
PLOS ONE, 2023, 18 (06):
[27] Comparative Genomic Structures of Mycobacterium CRISPR-Cas
He, Liming
Fan, Xiangyu
Xie, Jianping
JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (07) : 2464 - 2473
[28] Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition
Kazlauskiene, Migle
Tamulaitis, Gintautas
Kostiuk, Georgij
Venclovas, Ceslovas
Siksnys, Virginijus
MOLECULAR CELL, 2016, 62 (02) : 295 - 306
[29] The CRISPR-Cas system in Enterobacteriaceae
Medina-Aparicio, Liliana
Davila, Sonia
Rebollar-Flores, Javier E.
Calva, Edmundo
Hernandez-Lucas, Ismael
PATHOGENS AND DISEASE, 2018, 76 (01):
[30] A short overview of the CRISPR-Cas adaptation stage
Mosterd, Cas
Rousseau, Genevieve M.
Moineau, Sylvain
CANADIAN JOURNAL OF MICROBIOLOGY, 2021, 67 (01) : 1 - 12

← 1 2 3 4 5 →